Critical Care (Apr 2020)

IL6-R blocking with tocilizumab in critically ill patients with hemophagocytic syndrome

  • Etienne Dufranc,
  • Arnaud Del Bello,
  • Julie Belliere,
  • Nassim Kamar,
  • Stanislas Faguer,
  • on behalf of the TAIDI (Toulouse Acquired Immune Deficiency and Infection) study group

DOI
https://doi.org/10.1186/s13054-020-02878-7
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 3

Abstract

Read online

No abstracts available.

Keywords